GSK plc
GSK
$37.56
$0.411.10%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.93B | 2.05B | 530.19M | -75.48M | 1.48B |
| Total Depreciation and Amortization | 1.55B | 1.04B | 257.41M | 1.24B | 806.10M |
| Total Amortization of Deferred Charges | -- | -- | 270.22M | -- | -- |
| Total Other Non-Cash Items | -116.22M | 123.43M | 2.54B | -524.43M | -475.59M |
| Change in Net Operating Assets | -559.71M | -1.76B | -613.43M | 2.17B | -406.20M |
| Cash from Operations | 2.80B | 1.44B | 2.98B | 2.80B | 1.40B |
| Capital Expenditure | -341.97M | -261.97M | -696.68M | -396.90M | -380.97M |
| Sale of Property, Plant, and Equipment | 6.68M | 1.26M | 78.12M | 1.30M | 2.52M |
| Cash Acquisitions | -4.01M | -1.01B | -83.24M | -5.21M | -41.63M |
| Divestitures | -37.40M | -1.26M | -6.40M | -3.90M | -8.83M |
| Other Investing Activities | -458.19M | -167.51M | -724.85M | -546.55M | 1.40B |
| Cash from Investing | -834.89M | -1.44B | -1.43B | -951.26M | 971.36M |
| Total Debt Issued | 645.00M | 2.08B | 1.34B | -- | -- |
| Total Debt Repaid | -1.57B | -216.00M | -1.15B | -604.00M | -596.00M |
| Issuance of Common Stock | 2.00M | 12.00M | 0.00 | 1.00M | 1.00M |
| Repurchase of Common Stock | -561.00M | -247.00M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -876.30M | -770.80M | -783.76M | -796.40M | -822.50M |
| Other Financing Activities | -230.00M | -156.00M | -418.00M | -25.00M | -337.00M |
| Cash from Financing | -3.17B | 1.08B | -1.08B | -1.61B | -2.00B |
| Foreign Exchange rate Adjustments | -34.73M | -13.85M | 8.96M | -44.24M | -10.09M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.24B | 1.07B | 480.25M | 193.90M | 367.10M |